Counsyl Raises $28M, Launches BRCA1/2 Testing | GenomeWeb

NEW YORK (GenomeWeb) – Genetic testing firm Counsyl today announced it raised $28 million in a Series D financing, and it has launched its BRACA1 and BRCA2 screening service.

The financing was co-led by Rosemont Seneca Technology Partners and Goldman Sachs Asset Management and brings the total amount raised by South San Francisco, Calif.-based Counsyl to $93 million, it said. The company will use the funds for product development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.